114 related articles for article (PubMed ID: 16827128)
1. Overexpression of p68 mRNA in head and neck squamous cell carcinoma cells.
Beier UH; Maune S; Meyer JE; Görögh T
Anticancer Res; 2006; 26(3A):1941-6. PubMed ID: 16827128
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Pim-1 in head and neck squamous cell carcinomas.
Beier UH; Weise JB; Laudien M; Sauerwein H; Görögh T
Int J Oncol; 2007 Jun; 30(6):1381-7. PubMed ID: 17487358
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of a novel lysyl oxidase-like gene in human head and neck squamous cell carcinomas.
Holtmeier C; Görögh T; Beier U; Meyer J; Hoffmann M; Gottschlich S; Heidorn K; Ambrosch P; Maune S
Anticancer Res; 2003; 23(3B):2585-91. PubMed ID: 12894545
[TBL] [Abstract][Full Text] [Related]
4. Differentially expressed genes in head and neck cancer.
Gottschlich S; Folz BJ; Lippert BM; Niemann AM; Goeroegh T; Werner JA
Laryngoscope; 1998 May; 108(5):639-44. PubMed ID: 9591538
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.
Canel M; Secades P; Rodrigo JP; Cabanillas R; Herrero A; Suarez C; Chiara MD
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3272-9. PubMed ID: 16740747
[TBL] [Abstract][Full Text] [Related]
6. [Detection of differentially expressed genes in head-neck carcinomas].
Werner JA; Gottschlich S; Görögh T; Folz BJ; Lippert BM; Niemann AM
Laryngorhinootologie; 1997 May; 76(5):300-7. PubMed ID: 9280417
[TBL] [Abstract][Full Text] [Related]
7. Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas.
Rost T; Pyritz V; Rathcke IO; Görögh T; Dünne AA; Werner JA
Anticancer Res; 2003; 23(2B):1565-73. PubMed ID: 12820424
[TBL] [Abstract][Full Text] [Related]
8. S19-mRNA expression in squamous cell carcinomas of the upper aerodigestive tract.
Sengpiel V; Rost T; Görögh T; Rathcke IO; Werner JA
Anticancer Res; 2004; 24(4):2161-7. PubMed ID: 15330156
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the human myosin-binding protein-C1 mRNA in laryngeal squamous cell carcinoma cells.
Beier UH; Görögh T; Holtmeier C; Ambrosch P; Maune S
Anticancer Res; 2002; 22(6A):3343-7. PubMed ID: 12530085
[TBL] [Abstract][Full Text] [Related]
10. Selective upregulation and amplification of the lysyl oxidase like-4 (LOXL4) gene in head and neck squamous cell carcinoma.
Görögh T; Weise JB; Holtmeier C; Rudolph P; Hedderich J; Gottschlich S; Hoffmann M; Ambrosch P; Csiszar K
J Pathol; 2007 May; 212(1):74-82. PubMed ID: 17354256
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
[TBL] [Abstract][Full Text] [Related]
12. Genes differentially expressed with malignant transformation and metastatic tumor progression of murine squamous cell carcinoma.
Dong G; Loukinova E; Smith CW; Chen Z; Van Waes C
J Cell Biochem Suppl; 1997; 28-29():90-100. PubMed ID: 9589353
[TBL] [Abstract][Full Text] [Related]
13. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.
Smith IM; Mithani SK; Liu C; Chang SS; Begum S; Dhara M; Westra W; Sidranksy D; Califano JA
Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):487-95. PubMed ID: 19451471
[TBL] [Abstract][Full Text] [Related]
14. Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma.
Woenckhaus J; Steger K; Werner E; Fenic I; Gamerdinger U; Dreyer T; Stahl U
J Pathol; 2002 Nov; 198(3):335-42. PubMed ID: 12375266
[TBL] [Abstract][Full Text] [Related]
15. Involvement of EphA2 in head and neck squamous cell carcinoma: mRNA expression, loss of heterozygosity and immunohistochemical studies.
Rivera RS; Gunduz M; Nagatsuka H; Gunduz E; Cengiz B; Fukushima K; Beder LB; Pehlivan D; Yamanaka N; Shimizu K; Nagai N
Oncol Rep; 2008 May; 19(5):1079-84. PubMed ID: 18425361
[TBL] [Abstract][Full Text] [Related]
16. [Re-amplification of differentially expressed mRNA fragments of head-neck cancers without cloning].
Weber EH; Gottschlich S; Lippert BM; Görögh T; Folz BJ; Eggers S; Werner JA
Laryngorhinootologie; 1998 Jan; 77(1):43-7. PubMed ID: 9522312
[TBL] [Abstract][Full Text] [Related]
17. Increase in gene dosage is a mechanism of HIF-1alpha constitutive expression in head and neck squamous cell carcinomas.
Secades P; Rodrigo JP; Hermsen M; Alvarez C; Suarez C; Chiara MD
Genes Chromosomes Cancer; 2009 May; 48(5):441-54. PubMed ID: 19235921
[TBL] [Abstract][Full Text] [Related]
18. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
[TBL] [Abstract][Full Text] [Related]
20. Implications of tropomyosin-related kinase B (TrkB) in head and neck cancer.
Zhu L; Werner JA; Mandic R
Anticancer Res; 2007; 27(5A):3121-6. PubMed ID: 17970052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
